News + Filings Holdings
|
Nikko Asset Management Americas, Inc.
> CRSP
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | CRISPR Therapeutics AG | CRSP | 3,533,357 | -438,782 | 198,327,328,000 | 19,581,073,000 | $56,130.00 |
| 03/31/2023 | CRISPR Therapeutics AG | CRSP | 3,972,139 | -290,597 | 178,746,255,000 | 178,469,177,000 | $45,000.00 |
| 09/30/2022 | CRISPR Therapeutics AG | CRSP | 4,262,736 | -321,362 | 277,078,000 | 1,024,000 | $65.00 |
| 06/30/2022 | CRISPR Therapeutics AG | CRSP | 4,584,098 | -35,649 | 276,054,000 | -14,990,000 | $60.22 |
| 03/31/2022 | CRISPR Therapeutics AG | CRSP | 4,619,747 | 300,276 | 291,044,000 | -39,482,000 | $63.00 |
| 12/31/2021 | CRISPR Therapeutics AG | CRSP | 4,319,471 | 1,029,955 | 327,329,512 | -41,096,488 | $75.78 |
| 09/30/2021 | CRISPR Therapeutics AG | CRSP | 3,289,516 | -370,349 | 368,426,000 | -77,529,000 | $112.00 |
| 03/31/2021 | CRISPR Therapeutics AG | CRSP | 3,659,865 | -176,958 | 445,955,000 | -141,501,000 | $121.85 |
| 12/31/2020 | CRISPR Therapeutics AG | CRSP | 3,836,823 | 139,156 | 587,455,970 | 278,700,970 | $153.11 |
| 09/30/2020 | CRISPR Therapeutics AG | CRSP | 3,697,667 | -14,303 | 308,755,000 | 39,637,000 | $83.50 |
| 06/30/2020 | CRISPR Therapeutics AG | CRSP | 3,711,970 | -54,571 | 269,118,000 | 109,379,000 | $72.50 |
| 03/31/2020 | CRISPR Therapeutics AG | CRSP | 3,766,541 | 716,988 | 159,739,000 | -25,994,000 | $42.41 |
| 12/31/2019 | CRISPR Therapeutics AG | CRSP | 3,049,553 | 272,139 | 185,733,025 | 71,887,025 | $60.91 |
| 09/30/2019 | CRISPR Therapeutics AG | CRSP | 2,777,414 | 906,006 | 113,846,000 | 25,703,000 | $40.99 |
| 06/30/2019 | CRISPR Therapeutics AG | CRSP | 1,871,408 | 1,430,364 | 88,143,000 | 72,389,000 | $47.10 |
| 03/31/2019 | CRISPR Therapeutics AG | CRSP | 441,044 | 440,120 | 15,754,000 | 15,728,000 | $35.72 |
| 12/31/2018 | CRISPR Therapeutics AG | CRSP | 924 | -200 | 26,000 | -24,000 | $28.14 |
| 09/30/2018 | CRISPR Therapeutics AG | CRSP | 1,124 | 1,124 | 50,000 | 50,000 | $44.48 |
| << Prev Next >> |
|